Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 2,961 shares at $16.48 ($49K) on 2020-02-19, disclosed to the SEC on 2020-02-21.
Open-market sale of $49k KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |